December 23, 2002: FDA approves EXTRANEAL (icodextrin), Baxter´s New Peritoneal Dialysis Solution
December 20, 2002: Baxter Completes Its Acquisition of ESI Lederle
December 20, 2002: Baxter International Foundation Awards $25,000 Grant to Lafayette House
December 20, 2002: Baxter to Acquire Alpha-1 Antitrypsin and other Assets from Alpha Therapeutic Corporation
December 13, 2002: YWCA Of Eastern Union County Receives $45,000 Baxter International Foundation Grant
December 12, 2002: Baxter Announces Pricing for Concurrent Securities Offerings
December 10, 2002: Baxter International Inc. Announces Concurrent Securities Offerings
December 10, 2002: Prevent Child Abuse - Orange County Receives $34,000 Grant From The Baxter International Foundation
December 6, 2002: Baxter Sets New Industry Standard with Enhanced Bar Coding and Information System Technology to Help Reduce Medication Errors
December 5, 2002: Home of The Sparrow Receives $19,000 Grant From The Baxter International Foundation
December 3, 2002: Baxter to Sell Services Component of Renal Business
December 2, 2002: Susan B. Anthony Recovery Center Receives $35,000 Grant From The Baxter International Foundation
November 21, 2002: Baxter Names Chief Information Officer John Moon a Corporate Vice President and Corporate Officer
November 21, 2002: Baxter Receives U.S. FDA Clearance to Market Accura Hemofiltration System
November 19, 2002: Baxter Declares Annual Dividend
November 18, 2002: Young & Healthy Receives $25,000 Grant From The Baxter International Foundation
November 14, 2002: The Baxter International Foundation Awards a $40,000 Challenge Grant to Life-Line
November 11, 2002: Baxter to Acquire Epic Therapeutics, Inc
November 5, 2002: Baxter Study Verifies Viral Inactivation of West Nile Virus From Its Plasma-Derived Therapies
November 4 , 2002: Baxter Sponsors Clinical National Hemophilia Foundation Fellowship Program
October 29, 2002: Hospice of the Conejo Receives $23,000 Grant for Bereavement and Companion Programs from Baxter International Foundation
October 23, 2002: The Baxter International Foundation Awards $60,000 to Improve Blood Safety in Developing Countries
October 18, 2002: Greater Baden Medical Services Receives $45,000 Grant From The Baxter International Foundation
October 17, 2002: Baxter´s Sales, Earnings Grow in Third Quarter
October 16, 2002: Baxter and Cerus Announce Final European Regulatory Clearance for the First Pathogen Inactivation System for Platelets
October 16, 2002: The Suncoast Health Council Receives $20,000 Grant From The Baxter International Foundation
October 7, 2002: Baxter´s PULSE Water + Nutrients Supplements Set to Splash Into Thirty-Four Additional U.S. States
October 3, 2002: Baxter Expects Low-Double-Digit Sales, Mid-Teens EPS Growth for Full-Year 2002
September 26, 2002: Baxter Files Marketing Authorization Application to EMEA for First Plasma/Albumin Free Method Recombinant Factor VIII Hemophilia Therapy
September 24, 2002: Baxter Pledges to Help Hospitals Reduce Waste Through Landmark Environmental Initiative
September 13, 2002: Baxter Advises Customers to Suspend Use of Certain
Bloodlines and Safety Fistula Needles as Investigation of Hemodialysis Treatments Continues
September 12, 2002: Baxter Receives FDA Clearance for Automated Blood Component Collection System
July 31, 2002: Baxter and International Society of Nephrology Announce First Round of Renal Discoveries Grant Program Winners
July 29, 2002: Baxter International Foundation Grants $200,000 to Global Polio Eradication Initiative
July 23, 2002: Baxter Highlights Economic, Social and Environmental Progress in its Third Annual Sustainability Report
July 18, 2002: Baxter´s Partnership with Local Nursery to Yield Environmental Benefits
July 18, 2002: Baxter Reports Second Quarter Results
July 16, 2002: Baxter Launches Mesnex (mesna) Tablets
July 15, 2002: Family and Children´s Service Receives $51,000 Grant from Baxter International Foundation
July 15, 2002: Baxter Begins Pivotal U.S., European Clinical Trials for New, Liquid Immune Globulin Product
July 10, 2002: Uninsured Crisis Solutions Should Focus on Small Business, Baxter International CEO Tells House Panel
July 8, 2002: Baxter International Foundation Gives $200,000 To Support a Strategic Partnership Between Ireland´s Western Health Board and the Royal Hospitals Trust in Northern Ireland
June 27, 2002: NAGA Receives $45,000 Grant from Baxter International Foundation [Italian translation]
June 27, 2002: Baxter Submits File to U.S. FDA for Marketing Approval of Plasma/Albumin Free Method Recombinate Factor VIII Hemophilia Therapy
June 25, 2002: Glendale Healthy Kids Receives $28,000 Grant from Baxter International Foundation
June 24, 2002: Dr. John M. Eisenberg Selected for the Prestigious Baxter International Foundation Health Services Research Prize
June 19, 2002: Baxter to Launch Vaccine in Germany to Protect Against Tick-Borne Encephalitis
June 19, 2002: YWCA of Lake County Receives $30,000 Challenge Grant from Baxter International Foundation
June 18, 2002: Baxter Healthcare Corporation and Northwestern University Announce Nanoscience Collaboration
June 10, 2002: Baxter to Significantly Expand Its Injectable Drug Portfolio and Manufacturing Capability with Acquisition of ESI Lederle
June 6, 2002: Los Angeles Free Clinic Receives $40,000 Grant from Baxter International Foundation
June 4, 2002: Cerus and Baxter´s INTERCEPT Disposable Set for Platelets Receives European Regulatory Approval
May 29, 2002: Baxter Adds Fifth "Put" Option to Its 1-1/4% Convertible Debentures Due June 1, 2021
May 28, 2002: Baxter Lauches Pulse, New Water + Nutrients Supplement
May 21, 2002: Baxter Introduces the BAXJECT Needleless Transfer Device at International Haemophilia Congress
May 15, 2002: Baxter´s Brian Anderson Named Chicago´s CFO of the Year
May 9, 2002: Baxter Is Named One of the Best Places To Work by Computerworld Magazine
May 7, 2002: Baxter Highlights Growth Initiatives at Annual Meeting of Shareholders
May 3, 2002: Baxter Completes Acquisition of Fusion Medical Technologies
May 3, 2002: Baxter Announces Approval of 25mL Presentation of Diltiazem Hydrochloride for Injection
April 30, 2002: Exchange Ratio Is Set for Baxter´s Acquisition of Fusion Medical Technologies
April 24, 2002: Shanghai Child Health Foundation Receives $25,000 Grant from Baxter International Foundation To Provide Health Care for 6,500 Children
April 23, 2002: Family Support America Honors Baxter With the Kathleen McDonald Memorial Work and Family Award
April 18, 2002: Newly Published Data Show At-Home Dialysis Therapy May Benefit More Patients
April 18, 2002: Strong First Quarter Positions Baxter Well To Meet Full Year 2002 Commitments
April 4, 2002: Baxter Unveils Three New Internet-Based Continuing Education Programs Focused on Safety in Clinical Practice
March 28, 2002: The Ceske Budejovice Centre Receives $15,000 Grant from Baxter International Foundation [Czech translation]
March 27, 2002: Northwest Assistance Ministries Receives $30,000 Grant from Baxter International Foundation
March 26, 2002: Love´s Circle Receives $47,844 Grant for Volunteer Coordination from Baxter International Foundation
March 25, 2002: Irvine Adult Day Health Center Receives $57,900 Grant From The Baxter International Foundation
March 18, 2002: Baxter Joins the Children´s World Blood Bank´s Efforts to Increase Access to a Safe Global Blood Supply for Children´s Worldwide
March 14, 2002: Baxter Highlights Growth Initiatives at Annual Investor Conference
March 14, 2002: Baxter Announces Agreements To Expand Renal Product Portfolio
March 13, 2002: Baxter International Foundation Awards $4.8 Million in 2001 to More Than 200 Organizations in 15 Countries
March 11, 2002: Baxter Announces the Locations of Two New,
State-of-the-Art Vaccine Production Facilities in Austria and Czech Republic
March 11, 2002: (German translation of above news release) Baxter stellt Standorte für zwei neue hochmoderne Produktionsstätten für Impfstoffe in Österreich und Tschechien vor
March 11, 2002: (Czech translation of above news release) Spoleènost Baxter vybuduje dva moderní závody na výrobu vakcín na èeském a rakouském trhu
March 8, 2002: Baxter´s Mountain Home Facility Recognized With OSHA´s Top Safety and Health Status
March 7, 2002: Baxter Signs Agreement to Acquire IV Business of India´s Wockhardt Lifesciences
February 27, 2002: Baxter International Inc., Names Harvard Medical School Dean to Board of Directors
February 27, 2002: Baxter Signs Agreement To Acquire Fusion
February 21, 2002: Meharry Medical College Receives $150, 000 Grant from The Baxter International Foundation
February 21, 2002: Cerus and Baxter Receive FDA Concurrence to Begin Phase III INTERCEPT Red Blood Cell Trial in Chronic Indications
February 19, 2002: NEW Community Clinic Receives $30,800 Grant from Baxter International Foundation Grant
February 11, 2002: Central Minnesota Task Force on Battered Women Receives $20,000 Baxter International Foundation Grant
February 11, 2002: Gozo´s Arka Foundation Receives $65,000 Grant from The Baxter International Foundation
January 24, 2002: Baxter´s Momentum Continues With Strong Performance Fourth Quarter, Full Year
January 9, 2002: Cerus and Baxter Initiate Clinical Site in Pivotal Phase III Trial for INTERCEPT Red BLood Cell System
January 7, 2002: Baxter Responds to Report by Croatian Investigators on Hazardous Dialyzer Substance
January 7, 2002: Baxter Produces Record Levels of Recombinate rAHF Hemophilia Therapy in 2001
January 4, 2002: Baxter Employee Goes Extra Mile for Hemophilia Community; Now to Serve as Olympic Torchbearer
January 3, 2002: Public Prosecutor in Sweden Closes Investigation
Print this page
